Technology assessment and cost-effectiveness analysis: misguided guidelines?
- 15 March 1993
- journal article
- editorial
- Vol. 148 (6), 921-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Incorporating variations in the quality of individual randomized trials into meta-analysisJournal of Clinical Epidemiology, 1992
- How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1992
- Health care technology assessment: linking science and policy-making.1992
- Potential cost effectiveness of intravenous tissue plasminogen activator versus streptokinase for acute myocardial infarction.1992
- Quality-adjusted life-years. Ethical implications for physicians and policymakersJAMA, 1990
- Where To Draw the Line against CholesterolAnnals of Internal Medicine, 1989
- Rules of evidence and clinical recommendations on the use of antithrombotic agents.1989
- Applications of cost-benefit analysis to health care: Departures from welfare economic theoryJournal of Health Economics, 1987
- Economic analysis and clinical trialsControlled Clinical Trials, 1984